One way to measure progress in fighting AIDS is to compare the number of new HIV infections with the increase in HIV positive people on antiretroviral therapy (ART) over a given time period. An AIDS epidemic reaches its “tipping point” when the number of annual new HIV infection falls below the annual increase in patients starting ART. Coverage matters. A first milestone is treating approximately two thirds of people in need in a given country. Once that level is reached, countries and advocates can track progress to the tipping point.
The Tipping Point
Ending AIDS Gamechangers
From the Ending AIDS report, a joint partnership between AVAC and amfAR. Visit www.endingaids.org for more information.
Achieving the End
Recent breakthroughs in HIV prevention research have created unprecedented opportunities to curb new HIV infections, save lives and set the world on a path towards eliminating HIV transmission.
Key Strategies for Closing Gaps in the HIV Treatment U=U Cascade
From the AVAC Report 2012, this infographic highlights an AVAC 2013 priority of articulating and funding a retention science agenda that narrows the gaps in the Treatment U=U cascade.
Plans and Missing Pieces in PrEP Demonstration Projects: USA
This infographic from AVAC Report 2012 identifies the design and key questions for ongoing or planned PrEP demonstration projects in the US.
Reaching the Tipping Point: The time to act is now
AVAC Playbook 2012-2013: Progress toward global goals
AVAC first published its Playbook of global goals for ending AIDS in late 2011. This infographic from the AVAC Report 2012 builds on the objectives from 2011 and identifies five priorities for action in 2013.
Estimated Engagement in HIV Care Cascade in the US
As this graphic from AVAC Report 2012 shows, it is estimated that only 19 percent of HIV-positive people in the the US have an undetectable viral load.
HIV Prevention Research: Defining moments since 2010
Published in AVAC Report 2011, this timeline shows the HIV prevention scientific breakthroughs from July 2010 to Nov 2011, including the CAPRISA 004, iPrEx and Partners PrEP trials.
Many Opportunities for HIV Prevention
To end AIDS, we need HIV prevention options that are highly effective before, during and after exposure or infection. This graphic from AVAC Report 2011 lists some of these tools.